A New Dosing Regimen for Nivolumab Plus Ipilimumab in Advanced Melanoma

Leggi l'articolo originale


The CheckMate 511 phase IIIb/IV trial investigated raising the nivolumab dose to 3 mg/kg and lowering the ipilimumab dose to 1 mg/kg.

Lascia un commento